FDA Approves New Treatment for Rare Blood Clotting Disorder

Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…

Read More

Senators Urge HHS to Expand Coverage for OTC Contraceptives

Many birth control pills are covered but require a prescription. Forty-eight senators wrote a letter to President Biden’s administration this week, advocating for healthcare to expand coverage to…

Read More

FDA Panel Votes for Over-the-Counter Birth Control Pill

The recommendation minimizes the dangers of the side effects. An advisory panel for the Food and Drug Administration (FDA) voted this week to recommend the over-the-counter sale of…

Read More

FTC Issues Letters on Eyeglass Rule

Prescribers must provide prescriptions must be provided to patients. The Federal Trade Commission has issued cease and desist letters to thirty-seven eyeglass prescribers, including ophthalmologist and optometrists, alerting…

Read More

Back to top
FE3